Xos, Inc. current report, 31 May 2023

Xos, Inc. Form 8-K Summary

Business Context and Reporting Period

Xos, Inc. reported the results of its virtual 2023 annual meeting of stockholders held on May 31, 2023. The Form 8-K was dated and signed June 6, 2023. Holders of 134,638,427 shares, representing 79.27% of the 169,829,056 shares outstanding as of the April 3, 2023 record date, were present in person or by proxy, constituting a quorum.

Key Financial and Corporate Metrics

This filing reports stockholder voting matters and does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics.

ProposalResultVotes ForVotes Against or WithheldAbstentions
Election of Alice Jackson as Class II director through the 2026 annual meetingApproved115,071,5863,433,723 withheldNot separately reported; 16,133,118 broker non-votes
Election of George Mattson as Class II director through the 2026 annual meetingApproved115,434,6053,070,704 withheldNot separately reported; 16,133,118 broker non-votes
Election of Giordano Sordoni as Class II director through the 2026 annual meetingApproved117,286,0581,219,251 withheldNot separately reported; 16,133,118 broker non-votes
Ratification of Grant Thornton LLP as independent registered public accounting firm for fiscal 2023Approved133,705,583209,285 against723,559
Reverse stock split amendment to the certificate of incorporationApproved133,361,616912,890 against363,921
Issuance of at least 20% of outstanding common stock under the Standby Equity Purchase Agreement with YA II PN, Ltd.Approved116,390,5191,549,093 against565,697
Issuance of at least 20% of outstanding common stock pursuant to convertible debentures with YA II PN, Ltd.Approved116,370,9531,563,844 against570,512
Issuance of at least 20% of outstanding common stock to Aljomaih Automotive Co.Approved116,823,4671,135,605 against546,237

Material Changes, Outlook, and Risks

  • All six proposals were approved, including authorization for a reverse stock split and three potential issuances of 20% or more of the company’s outstanding common stock.
  • The approved issuances could result in substantial equity dilution. The filing does not state the timing, final size, pricing, or terms of any issuance.
  • The reverse stock split was approved, but this filing does not specify the split ratio, effective date, or whether it had been implemented as of the filing date.
  • Approval of the Yorkville-related proposals supports the company’s ability to access the Standby Equity Purchase Agreement and convertible debenture financing arrangements, subject to their terms and applicable conditions.
  • No management financial guidance, operating outlook, contingencies, or unusual accounting items are provided.

Investor Verification Items

  • Verify the final reverse stock split ratio, implementation date, and resulting share count.
  • Review the Yorkville financing agreements and determine the potential maximum dilution, conversion terms, and funding conditions.
  • Confirm the terms and timing of any issuance to Aljomaih Automotive Co.
  • Assess the company’s subsequent filings for actual equity issuances, changes in outstanding shares, and related proceeds.
  • Review subsequent periodic reports for the company’s financial condition, liquidity, cash requirements, and going-concern or financing risks, which are not addressed in this filing.